ExcelMale
Menu
Home
What's new
Latest activity
Forums
New posts
Search forums
What's new
New posts
Latest activity
Videos
Lab Tests
Doctor Finder
Buy Books
About Us
Men’s Health Coaching
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Navigation
Install the app
Install
More options
Contact us
Close Menu
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Neglected side effects to curative prostate cancer treatments
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="madman" data-source="post: 192626" data-attributes="member: 13851"><p><strong>Neglected side effects to curative prostate cancer treatments</strong></p><p>Alexander B. Nolsøe ● Christian Fuglesang S. Jensen ● Peter B. Østergren ● Mikkel Fode</p><p></p><p></p><p></p><p></p><p><strong>Abstract</strong></p><p><strong></strong></p><p><strong>In this narrative review, we summarize the neglected side effects of curative intended treatment for prostate cancer. <u>They include climacturia, arousal incontinence (AI), orgasmic disturbances such as altered orgasmic sensation, anorgasmia, and orgasm associated pain (dysorgasmia), ejaculatory dysfunction, and morphological penile alterations in the form of shortening and deformity</u>. </strong>Even though they have not received as much interest as erectile dysfunction (ED) or urinary incontinence, these side effects have been shown to negatively impact the patient’s quality of life. <strong><u>They are common and rates of climacturia after radical prostatectomy (RP) range from 20% and 45%, less after external beam radiation therapy (EBRT)</u>. <u>Decreased orgasmic sensation ranges from 3.9% to 60% after RP and between 36–57% after EBRT</u>. <u>Dysorgasmia ranges from 9.5–15% for both RP and EBRT. Anejaculation after EBRT ranges from 11–71% and rates of penile shortening are reported between 0 and 100%</u>.</strong> There are no internationally validated questionnaires that adequately assess these side effects. This is necessary if we are to align patient and partner expectations properly and consequently manage them optimally. Neglected side effects should be discussed with patients and their partners preoperatively, as they are associated with bother and may lead to patients avoiding sexual activity.</p><p></p><p></p><p></p><p></p><p></p><p><strong>Introduction</strong></p><p><strong></strong></p><p><strong>Prostate cancer has an estimated worldwide incidence of 1.3 million and mortality of 359,000 [1] per year. <u>Established curative treatments include radical prostatectomy (RP), external beam radiation therapy (EBRT) possibly in combination with androgen deprivation therapy, and brachytherapy</u>. <u>The 10-year prostate cancer-specific survival rates for EBRT and RP ~99% [2] so attention should be paid to the adverse effects caused by treatments</u>. </strong>Regarding functional outcomes, most attention has gone toward erectile dysfunction (ED), urinary incontinence (UI), and bowel dysfunction [3, 4]. However, there are a wide range of sexual side effects that are often overlooked even though they are common [5, 6] and affect patients’ quality of life [5, 7]. They have received increasing interest and are collectively termed “Neglected side effects” [5]. They include climacturia, arousal incontinence (AI), orgasmic and ejaculatory disturbances, and penile anatomical changes. In this narrative review, we gave an interest in original research reporting on side effects other than the only UI and/or ED from January 1990 to April 2020. <strong><u>The aim is to summarize the neglected side effects following the different curative treatments for prostate cancer</u>.</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>*Climacturia</strong></p><p><strong></strong></p><p><strong>*Arousal incontinence</strong></p><p><strong></strong></p><p><strong>*Orgasmic and ejaculatory disturbances</strong></p><p><strong></strong></p><p><strong>*Altered orgasmic sensation and anorgasmia</strong></p><p><strong></strong></p><p><strong>*Dysorgasmia</strong></p><p><strong></strong></p><p><strong>*Ejaculatory dysfunction</strong></p><p><strong></strong></p><p><strong>*Penile anatomical changes</strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong></strong></p><p><strong>Conclusion </strong></p><p><strong></strong></p><p><strong><u>With the wide range of different sexual side effects, it seems obvious that too much emphasis is put on ED and so-called penile rehabilitation after curative treatment for prostate cancer</u>. There is a need adequate for internationally validated questionnaires. Further, more research is needed to identify possible treatments, and studies on brachytherapy are warranted to compare side effects across treatments and inform patients properly. <u>More importantly, the post-treatment focus needs to be shifted to much broader sexual rehabilitation programs</u>. <u>As similar side effects may cause different degrees of bother, such programs need to incorporate the needs and wishes of patients and their partners and consider the specific sexual practices of individual men</u>. <u>The main goal is to facilitate a feasible and pleasurable sexual life</u>. </strong></p></blockquote><p></p>
[QUOTE="madman, post: 192626, member: 13851"] [B]Neglected side effects to curative prostate cancer treatments[/B] Alexander B. Nolsøe ● Christian Fuglesang S. Jensen ● Peter B. Østergren ● Mikkel Fode [B]Abstract In this narrative review, we summarize the neglected side effects of curative intended treatment for prostate cancer. [U]They include climacturia, arousal incontinence (AI), orgasmic disturbances such as altered orgasmic sensation, anorgasmia, and orgasm associated pain (dysorgasmia), ejaculatory dysfunction, and morphological penile alterations in the form of shortening and deformity[/U]. [/B]Even though they have not received as much interest as erectile dysfunction (ED) or urinary incontinence, these side effects have been shown to negatively impact the patient’s quality of life. [B][U]They are common and rates of climacturia after radical prostatectomy (RP) range from 20% and 45%, less after external beam radiation therapy (EBRT)[/U]. [U]Decreased orgasmic sensation ranges from 3.9% to 60% after RP and between 36–57% after EBRT[/U]. [U]Dysorgasmia ranges from 9.5–15% for both RP and EBRT. Anejaculation after EBRT ranges from 11–71% and rates of penile shortening are reported between 0 and 100%[/U].[/B] There are no internationally validated questionnaires that adequately assess these side effects. This is necessary if we are to align patient and partner expectations properly and consequently manage them optimally. Neglected side effects should be discussed with patients and their partners preoperatively, as they are associated with bother and may lead to patients avoiding sexual activity. [B]Introduction Prostate cancer has an estimated worldwide incidence of 1.3 million and mortality of 359,000 [1] per year. [U]Established curative treatments include radical prostatectomy (RP), external beam radiation therapy (EBRT) possibly in combination with androgen deprivation therapy, and brachytherapy[/U]. [U]The 10-year prostate cancer-specific survival rates for EBRT and RP ~99% [2] so attention should be paid to the adverse effects caused by treatments[/U]. [/B]Regarding functional outcomes, most attention has gone toward erectile dysfunction (ED), urinary incontinence (UI), and bowel dysfunction [3, 4]. However, there are a wide range of sexual side effects that are often overlooked even though they are common [5, 6] and affect patients’ quality of life [5, 7]. They have received increasing interest and are collectively termed “Neglected side effects” [5]. They include climacturia, arousal incontinence (AI), orgasmic and ejaculatory disturbances, and penile anatomical changes. In this narrative review, we gave an interest in original research reporting on side effects other than the only UI and/or ED from January 1990 to April 2020. [B][U]The aim is to summarize the neglected side effects following the different curative treatments for prostate cancer[/U]. *Climacturia *Arousal incontinence *Orgasmic and ejaculatory disturbances *Altered orgasmic sensation and anorgasmia *Dysorgasmia *Ejaculatory dysfunction *Penile anatomical changes Conclusion [U]With the wide range of different sexual side effects, it seems obvious that too much emphasis is put on ED and so-called penile rehabilitation after curative treatment for prostate cancer[/U]. There is a need adequate for internationally validated questionnaires. Further, more research is needed to identify possible treatments, and studies on brachytherapy are warranted to compare side effects across treatments and inform patients properly. [U]More importantly, the post-treatment focus needs to be shifted to much broader sexual rehabilitation programs[/U]. [U]As similar side effects may cause different degrees of bother, such programs need to incorporate the needs and wishes of patients and their partners and consider the specific sexual practices of individual men[/U]. [U]The main goal is to facilitate a feasible and pleasurable sexual life[/U]. [/B] [/QUOTE]
Insert quotes…
Verification
Post reply
Share this page
Facebook
Twitter
Reddit
Pinterest
Tumblr
WhatsApp
Email
Share
Link
Sponsors
Forums
Testosterone Replacement, Low T, HCG, & Beyond
Prostate Related Issues
Neglected side effects to curative prostate cancer treatments
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.
Accept
Learn more…
Top